MAG-EPA resolves lung inflammation in an allergic model of asthma

Clinical and Experimental Allergy

Volumn 43, Issue 9, 2013, Pages 1071-1082

  Morin, C ^a,b   Fortin, S ^a   Cantin, A M ^c   Rousseau, É ^b  

^a SCF Pharma   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Asthma; COX 2; EPA; MUC5AC; Pro inflammatory cytokines

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; EICOSAPENTAENOIC ACID MONOACYLGLYCERIDE; EOTAXIN; ICOSAPENTAENOIC ACID; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; METHACHOLINE; MUCIN; MUCIN 5AC; OVALBUMIN; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS MUSCLE; CONTROLLED STUDY; EXPERIMENTAL GUINEA PIG; FEMALE; HOMOGENATE; HYPERSENSITIVITY; IN VIVO STUDY; INFLAMMATORY CELL; LEUKOCYTE COUNT; MALE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

ASTHMA; COX-2; EPA; MUC5AC; PRO-INFLAMMATORY CYTOKINES;

ALLERGENS; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; FATTY ACIDS; FEMALE; GUINEA PIGS; LUNG; MALE; MONOGLYCERIDES; MUCINS; OVALBUMIN; RECEPTORS, CHEMOKINE;

EID: 84882808919     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12162     Document Type: Article

References (43)

1. Bahadori K, Doyle-Waters MM, Marra C et al. Economic burden of asthma: a systematic review. BMC Pulm Med 2009; 9:24.
2. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161:1720-45.
3. Mitzner W, Brown RH. Potential mechanism of hyperresponsive airways. Am J Respir Crit Care Med 2000; 161:1619-23.
4. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008; 8:218-30.
5. Murdoch JR, Lloyd CM. Chronic inflammation and asthma. Mutat Res 2010; 690:24-39.
6. Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med 1998; 158:1585-92.
7. Gagliardo R, Chanez P, Mathieu M et al. Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am J Respir Crit Care Med 2003; 168:1190-8.
8. Connor WE. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 2000; 71(1 Suppl):171S-5S.
9. Morin C, Fortin S, Cantin AM, Rousseau E. Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-Potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma. Am J Respir Cell Mol Biol 2011; 45:366-75.
10. Freedman SD, Blanco PG, Zaman MM et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004; 350:560-9.
11. Peat JK, Mihrshahi S, Kemp AS et al. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. J Allergy Clin Immunol 2004; 114:807-13.
12. Jump DB. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 2002; 13:155-64.
13. Serhan CN, Hong S, Gronert K et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002; 196:1025-37.
14. Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem Rev 2011; 111:5922-43.
15. Sijben JW, Calder PC. Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Proc Nutr Soc 2007; 66:237-59.
16. Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 2003; 278:14677-87.
17. Levy BD, Kohli P, Gotlinger K et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol 2007; 178:496-502.
18. Serhan CN, Gotlinger K, Hong S et al. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 2006; 176:1848-59.
19. Aoki H, Hisada T, Ishizuka T et al. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun 2008; 367:509-15.
20. Arita M, Bianchini F, Aliberti J et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005; 201:713-22.
21. Fortin S. Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof. US819690 (2012) & US8222295 (2012).
22. Fortin S. Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof. CA2677670 (2010) & US8119690 (2011).
23. Morin C, Fortin S, Cantin AM et al. Anti-Cancer Effects of a New Docosahexaenoic Acid Monoacylglyceride in Lung Adenocarcinoma. Recent Pat Anticancer Drug Discov 2013; 8:319-34.
24. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22:659-61.
25. Morin C, Sirois M, Echave V, Albadine R, Rousseau E. 17, 18-epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase. Am J Respir Cell Mol Biol 2010; 43:564-75.
26. Gagne S, Crane S, Huang Z, Li CS, Bateman KP, Levesque JF. Rapid measurement of deuterium-labeled long-chain fatty acids in plasma by HPLC-ESI-MS. J Lipid Res 2007; 48:252-9.
27. King GG, Paré PD, Seow CY. The mechanics of exaggerated airway narrowing in asthma: the role of smooth muscle. Respir Physiol 1999; 118:1-13.
28. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 2007; 178:3912-7.
29. Ohira T, Arita M, Omori K, Recchiuti A, Van Dyke TE, Serhan CN. Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J Biol Chem 2010; 285:3451-61.
30. Calder PC. Fatty acids and gene expression related to inflammation. Nestle Nutr Workshop Ser Clin Perform Programme 2002; 7:19-36.
31. Bilal S, Haworth O, Wu L, Weylandt KH, Levy BD, Kang JX. Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses. Biochim Biophys Acta 2011; 1812:1164-9.
32. Marcheselli VL, Hong S, Lukiw WJ et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 2003; 278:43807-17.
33. Kohli P, Levy BD. Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol 2009; 158:960-71.
34. Dyerberg J, Madsen P, Møller JM, Aardestrup I, Schmidt EB. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids 2010; 83:137-41.
35. Cruz-Hernandez C, Thakkar SK, Moulin J et al. Benefits of structured and free monoacylglycerols to deliver eicosapentaenoic (EPA) in a model of lipid malabsorption. Nutrients. 2012; 4:1781-93.
36. Siddiqui S, Hollins F, Saha S, Brightling CE. Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Eur Respir J 2007; 30:1043-56.
37. Kinsella JE, Lokesh B, Stone RA. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr 1990; 52:1-28.
38. Kinsella JE, Dixit VM. Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol 2011; 187:597-602.
39. Nathan C, Ding A. Nonresolving inflammation. Cell 2010; 140:871-82.
40. Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol 2008; 9:873-9.
41. El Kebir D, Gjorstrup P, Filep JG. Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proc Natl Acad Sci U S A 2012; 109:14983-8.
42. Haworth O, Cernadas M, Levy BD. NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation. J Immunol 2011; 186:6129-35.
43. Luangsay S, Wittamer V, Bondue B et al. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J Immunol 2009; 183:6489-99.